Sung Hun Kang

Title: Innovations by Sung Hun Kang in Oral Gene Delivery

Introduction

Sung Hun Kang is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of gene delivery, particularly through his innovative approaches to oral gene carriers. With a total of 2 patents, his work focuses on developing systems that can effectively deliver genes to treat metabolic diseases.

Latest Patents

One of his latest patents is titled "Oral gene carrier and use thereof." This invention relates to an orally-administered gene carrier that comprises a linker formed from cationic arginine at the C-terminus of an immunoglobulin Fc region. This carrier is designed to condense an anionic gene and is particularly useful for preventing, ameliorating, or treating metabolic diseases such as diabetes and obesity by effectively transferring the GLP-1 gene.

Another significant patent is "Orally administered nanoparticles for gene delivery and pharmaceutical composition containing same." This invention presents a novel oral gene delivery system capable of regulating blood glucose levels and insulin secretion in response to meals. The nanoparticle for gene delivery comprises an ionic polymer conjugated with bile acid or a bile acid derivative, along with a gene, and is included in a pharmaceutical composition.

Career Highlights

Sung Hun Kang is currently associated with Kb Biomed Inc., where he continues to advance his research in gene delivery systems. His work is pivotal in the development of innovative solutions for metabolic diseases, showcasing his commitment to improving health outcomes through scientific advancements.

Collaborations

He collaborates with notable colleagues, including Yong-Kyu Lee and Dong Yun Lee, who contribute to his research endeavors and innovations in the field.

Conclusion

Sung Hun Kang's contributions to oral gene delivery represent a significant advancement in medical technology. His innovative patents and ongoing research hold promise for the treatment of metabolic diseases, highlighting the importance of his work in the scientific community.